M OZANIMOD (is an active metabolite) | OZANIMOD | ATC L04AE02
IMMUNOSUPPRESSANTS IMMUNOMODULATING SPHINGOSINE 1- PHOSPHATE RECEPTOR (SIP) MODULATOR TREATMENT OF RELAPSING FORMS OF MULTIPLE SCLEROSIS (MS) | - | PPB 99.3 PERCENT HT 264 HOUR | SPHINGOSINE 1- PHOSPHATE RECEPTORS S1P 1 AND 5 | Sphingosine 1-phosphate receptor 1 UNIPROT P21453 S1PR1 -- Sphingosine 1-phosphate receptor 5 UNIPROT Q9H228 S1PR5 more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |
OZANIMOD (has an active metabolite) | OZANIMOD | ATC L04AE02
IMMUNOSUPPRESSANTS IMMUNOMODULATING SPHINGOSINE 1- PHOSPHATE RECEPTOR (SIP) MODULATOR TREATMENT OF RELAPSING FORMS OF MULTIPLE SCLEROSIS (MS) | ORAL | Cmax 0.6 NANOMOLAR Tmax 7 HOUR VD 5590 LITER PPB 98.2 PERCENT Cl 192 LITER / HOUR HT 21 HOUR SOLUBILITY FREELY SOLUBLE IN WATER | SPHINGOSINE 1- PHOSPHATE RECEPTORS S1P 1 AND 5 PDB 7EW0 (CRYO-EM STRUCTURE OF OZANIMOD -BOUND SPHINGOSINE-1-PHOSPHATE RECEPTOR 1 IN COMPLEX WITH GI PROTEIN) LIGAND CODE = JEU (link to the list of PDB complexes) Download experimental 3D coordinates of JEU with added hydrogens | Sphingosine 1-phosphate receptor 1 UNIPROT P21453 S1PR1 -- Sphingosine 1-phosphate receptor 5 UNIPROT Q9H228 S1PR5 more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |